CDMO Services
Process Development
cGMP Manufacturing
Aseptic Fill/Finish
Bioanalytics
Factory Solutions
FastPharming
®
Tech
Plant Based Manufacturing
Glycan Engineering
About
What We Do
Partners
Team
Careers
Contact Us
Resources
Articles
News
Events
Scientific Publications
Therapeutics and Vaccines
Overview
Fibrosis
IBIO-100
COVID-19
IBIO-200 VLP Vaccine
IBIO-201 Subunit Vaccine
Classical Swine Fever
IBIO-400
Virus-Like Particles
LicKM
Investors
Contact Us
FastPharming
™ Tech
FastPharming
®
Advantages of Plant Based Protein Production
Fast.
FastPharming
shortens timelines to the clinic and can move a program from gene sequence to protein production in as little as three weeks.
Economical.
No expensive, labor-intensive, and costly cell line development
Quality.
Production of consistent therapeutics that are well-accepted by global regulatory bodies
Scalable.
No time-consuming scale-up challenges
Safe.
Mammalian viruses can’t grow in plants, so iBio’s plant-based production platform minimizes contamination risks.
No animal products or animal-derived components are used at any point in
FastPharming.
No inherent adventitious agents and no competency for agent replication
Vector Design
Bioreactor Growth
Vector Mobilization
Gene Transfer
Bioreactor Harvest and Protein Extraction
Protein Purification, Formulation and Fill/Finish